mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.7 |